Option chain shows key data for Verano Holdings's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Verano Holdings.

Verano Holdings (OTC:VRNOF) Stock, Option Chain

Verano Holdings

Verano Holdings Corp is a vertically integrated multi‐state cannabis operator in the United States. The Company has two reportable segments: (i) cultivation (wholesale) and (ii) retail. The company's consumer brands include Encore, Avexia, MÜV, Savvy, BITS and Verano. The company's retail dispensaries operate under brands including Zen Leaf and MÜV. The company derives its revenues from Retail segment.

AI-Generated Image

Analyst Color

Cannabis

Macro Economic Events

Market Summary

Mid Cap

News

Retail Sales

Economics

Exclusives

Markets

Analyst Ratings

Trading Ideas

THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC.

CBSTF

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GRAM

GTBIF

VRNOF

The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration.

Can Trump&#39;s Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning

cannabis, stock market, trading, earnings Business,Cannabis,Leaves,Marijuana,Stock,Exchange,Market,Or,Trading,Analysis

Earnings

Verano Q3 Revenue Slips, Losses Widen Amid Retail Decline In Key States

Screen Shot 2024-11-06 at 11.09.48

Politics

Legal

Movers

MSOS

NLCP

TCNNF

Florida and the Dakotas reject cannabis measures, while Nebraska approves medical cannabis and Dallas decriminalizes. Explore each state&#39;s path forward.

Cannabis Reform Stumbles In 2024 Elections: A State-By-State Breakdown As Stocks Take A Hit

VERANO HLDGS CORP by Verano Holdings Corp.

Verano Holdings Corp

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) with a Buy and raises the price target from $4 to $5.5.

Price Target

HC Wainwright & Co. Maintains Buy on Quantum-Si, Raises Price Target to $5.5

This collaboration aims to accelerate the development of advanced ceramic-based microspheres, a groundbreaking advancement in radiotherapeutic applications.
The partnership will see SINTX leverage its expertise in ceramic manufacturing to support NED medical's pre-clinical testing needs and perform the necessary process validation and verification activities to transition the microsphere process from the R&amp;D scale to pilot production.

SINT

SINTX  Signs Joint Development Agreement With NED Medical To Develop Next Generation Radiotherapeutic Solutions That May Have Transformative Impact On Cancer Treatment

Shoe Carnival (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.67 by 5.97 percent. The company reported quarterly sales of $306.885 million which missed the analyst consensus estimate of $316.950 million by 3.18 percent. This is a 4.07 percent decrease over sales of $319.914 million the same period last year.

Earnings Beats

Earnings Misses

SCVL

Shoe Carnival Q3 2024 Adj. EPS $0.71 Beats $0.67 Estimate, Sales $306.885M Miss $316.950M Estimate

Guidance

GEHC

GE HealthCare Sets Medium-Term 2026-2028 Targets: Organic Revenue Growth Mid-Single Digit (4% - 6%), Adjusted EPS Growth High-Single Digit To Low-Double Digit

Keefe, Bruyette &amp; Woods analyst Damon Delmonte initiates coverage on Northeast Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBN#NASDAQ">NBN</a>) with a Market Perform rating and announces Price Target of $102.

Initiation

Keefe, Bruyette & Woods Initiates Coverage On Northeast Bank with Market Perform Rating, Announces Price Target of $102

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Biomea Fusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) with a Buy and maintains $40 price target.

Reiteration

BMEA

HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $40 Price Target

GE HealthCare Reiterates 2024 Outlook For Organic Revenue Growth Trending Toward Lower End Of 1% - 2% Range; Continues To See Adjusted EPS $4.25 - $4.35 (Est $4.29)

Contracts

Media

General

Mega Matrix Signed A Memorandum Of Understanding With 9Yards Cinema Production To Jointly Establish An Investment Fund Focused On The Development Of Global Short Drama And Pan-entertainment Sector

Goldman Sachs analyst Catherine O'Brien reinstates AerCap Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AER#NYSE">AER</a>) with a Buy and announces $119 price target.

Goldman Sachs Reinstates Buy on AerCap Holdings, Announces $119 Price Target

HC Wainwright &amp; Co. analyst Kevin Dede reiterates Canaan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) with a Buy and maintains $3 price target.

HC Wainwright & Co. Reiterates Buy on Canaan, Maintains $3 Price Target

<a href="https://www.bloomberg.com/news/articles/2024-11-21/uber-said-to-be-in-talks-to-invest-in-us-ipo-of-china-s-pony-ai" title="https://www.bloomberg.com/news/articles/2024-11-21/uber-said-to-be-in-talks-to-invest-in-us-ipo-of-china-s-pony-ai">https://www.bloomberg.com/news/articles/2024-11-21/uber-said-to-be-in-talks-to-invest-in-us-ipo-of-china-s-pony-ai</a>

IPOs

UBER

Bloomberg Reported Earlier, Uber Said To Be In Talks To Invest In US IPO Of China's Pony AI

The dividend will be payable on February 14, 2025 to all shareholders of record as of January 14, 2025.

Dividends

GE HealthCare Boosts Q4 Cash Dividend By 17% From $0.03 To $0.035 Per Share

HC Wainwright &amp; Co. analyst Kevin Dede reiterates Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) with a Neutral.

ARBK

HC Wainwright & Co. Reiterates Neutral on Argo Blockchain

Deere (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) reported quarterly earnings of $4.55 per share which beat the analyst consensus estimate of $3.90 by 16.67 percent. This is a 44.92 percent decrease over earnings of $8.26 per share from the same period last year. The company reported quarterly sales of $11.143 billion which beat the analyst consensus estimate of $9.335 billion by 19.37 percent. This is a 27.70 percent decrease over sales of $15.412 billion the same period last year.

Deere Q4 2024 GAAP EPS $4.55 Beats $3.90 Estimate, Sales $11.143B Beat $9.335B Estimate

<ul>
<li>Full-year 2025 Net sales expected to be in the range of $2.9 - $3.2 billion</li>
<li>Full-year 2025 Adjusted EBITDA outlook of $475 - $525 million; Full-year Adjusted net income per diluted share outlook of $7.80 - $8.90</li>
</ul>

ATKR

Atkore 2025 Outlook: Expects Adjusted EPS Of $7.80 - $8.90 Vs. Est. $11.72, Net Sales Of $2.9B - $3.2B Vs. $3.0B Est.

Goldman Sachs analyst Catherine O'Brien reinstates Air Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AL#NYSE">AL</a>) with a Buy and announces $65 price target.

Goldman Sachs Reinstates Buy on Air Lease, Announces $65 Price Target

Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.63 by 9.52 percent. The company reported quarterly sales of $83.749 million which missed the analyst consensus estimate of $86.200 million by 2.84 percent. This is a 3.33 percent increase over sales of $81.053 million the same period last year.

ITRN

Ituran Location & Control Q3 2024 GAAP EPS $0.69 Beats $0.63 Estimate, Sales $83.749M Miss $86.200M Estimate

GE HealthCare Updates Medium-term Framework With Progress Toward Financial Goals; Boosts Quarterly Cash Dividend By Approximately 17%

Lotus Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) reported quarterly losses of $(0.30) per share. This is a 18.92 percent increase over losses of $(0.37) per share from the same period last year. The company reported $254.71 million in sales this quarter. This is a 35.55 percent increase over sales of $187.91 million the same period last year.

Lotus Technology Q3 EPS $(0.30) Up From $(0.37) YoY, Sales $254.71M Up From $187.91M YoY

Atkore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATKR#NYSE">ATKR</a>) reported quarterly earnings of $2.43 per share which missed the analyst consensus estimate of $2.47 by 1.62 percent. The company reported quarterly sales of $788.296 million which beat the analyst consensus estimate of $749.542 million by 5.17 percent. This is a 9.38 percent decrease over sales of $869.889 million the same period last year.

Atkore Q4 2024 Adj. EPS $2.43 Misses $2.47 Estimate, Sales $788.296M Beat $749.542M Estimate

Verano Holdings Corp. ( ($VRNOF) ) has released its Q3 earnings. Here is a breakdown of the information Verano Holdings Corp. presented to its inve...

Verano Holdings Reports Q3 2024 Financial Results

Canaccord analyst Matt Bottomley lowered the firm's price target on Verano Holdings (VRNOF) to C$13 from C$16.50 and keeps a Buy rating on the shar...

Verano Holdings price target lowered to C$13 from C$16.50 at Canaccord

Verano Holdings Corporation (VRNOF) Q3 2024 Earnings Call Transcript

Verano Holdings Corp. 2024 Q3 - Results - Earnings Call Presentation

Avoid Canopy Growth

Warning: VRNOF is at high risk of performing badly

Weed stocks spike after report on Trump support for marijuana reforms

Cannabis stocks gain as Trump picks pro-marijuana Congressman Gaetz for AG post

Verano Holdings (TSE:VRNO) has released an update. Verano Holdings has expanded its presence in New Jersey with the opening of Zen Leaf Mount Holly...

Verano Holdings Expands with New Jersey Dispensary

Seaport Research lowered the firm's price target on Verano Holdings (VRNOF) to $9 from $10.50 and keeps a Buy rating on the shares. The firm believ...

Verano Holdings price target lowered to $9 from $10.50 at Seaport Research

AAWH

ACRHF

AYRWF

CNBS

CRON

JUSHF

PLNH

TLRY

TSNDF

YOLO

Press Releases

TYSON 2.0 Strengthens Presence in Florida and Illinois with Leading Multistate Operator Verano

Verano Announces Closing of Acquisition of Arizona and Virginia Subsidiaries of The Cannabist Company, Becomes Exclusive Cannabis Operator for HSA 5 in Eastern Virginia and Strengthens Arizona Footprint

Verano Announces Upcoming Conference Participation

Verano Elevates Florida Retail Footprint to 79 Dispensaries with the Openings of MÜV Melbourne and MÜV Okeechobee

Verano Launches "Save the Bits" Fundraising Campaign, Featuring BITS™ Edibles and Industrywide Coalition of Hundreds of Dispensaries Across Eight States, Supporting the Lynn Sage Breast Cancer Foundation

Comments

Verano Holdings

Verano Holdings (VRNOF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga